API Holdings, the parent company of online pharmacy unicorn PharmEasy, is turning once again to debt markets to manage its obligations. The company announced that it will raise Rs 1,700 crore ($193 million) through redeemable non-convertible debentures (NCDs), pledging the shares of its listed subsidiary Thyrocare Technologies to secure the deal.
The proceeds from this fresh round of borrowing…
